Abstract
Use of oral contraceptives with estrogen and hormone replacement therapy with estrogen or testosterone are associated with increased risk of venous thromboembolism (VTE). However, whether endogenous estradiol and testosterone concentrations also associate with risk of VTE is unknown.
Original language | English |
---|---|
Journal | Journal of thrombosis and haemostasis : JTH |
Volume | 12 |
Issue number | 3 |
Pages (from-to) | 297-305 |
ISSN | 1538-7933 |
DOIs | |
Publication status | Published - 2014 |